Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1099141.RAhPwWF9o6pyDluqa89zdze90PwhP6AfSgiY6oii6hnAc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1099141.RAhPwWF9o6pyDluqa89zdze90PwhP6AfSgiY6oii6hnAc130_assertion type Assertion NP1099141.RAhPwWF9o6pyDluqa89zdze90PwhP6AfSgiY6oii6hnAc130_head.
- NP1099141.RAhPwWF9o6pyDluqa89zdze90PwhP6AfSgiY6oii6hnAc130_assertion description "[Significantly higher levels of CNP mRNA expression were found in HF patients as a function of clinical severity (C=0.23�0.058, NYHA I-II=0.47�0.18, NYHA III-IV=2.58�0.71, p=0.005 C vs NYHA III-IV, p=0.017 NYHA I-II vs NYHA III-IV) and NPR-B transcript levels resulted down-regulated in HF patients with higher NYHA class (C=2.2�0.61, NYHA I-II=2.76�0.46, NYHA III-IV=0.29�0.13, p=0.001 C vs NYHA III-IV, p<0.0001 NYHA I-II vs NYHA III-IV).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1099141.RAhPwWF9o6pyDluqa89zdze90PwhP6AfSgiY6oii6hnAc130_provenance.
- NP1099141.RAhPwWF9o6pyDluqa89zdze90PwhP6AfSgiY6oii6hnAc130_assertion evidence source_evidence_literature NP1099141.RAhPwWF9o6pyDluqa89zdze90PwhP6AfSgiY6oii6hnAc130_provenance.
- NP1099141.RAhPwWF9o6pyDluqa89zdze90PwhP6AfSgiY6oii6hnAc130_assertion SIO_000772 23911666 NP1099141.RAhPwWF9o6pyDluqa89zdze90PwhP6AfSgiY6oii6hnAc130_provenance.
- NP1099141.RAhPwWF9o6pyDluqa89zdze90PwhP6AfSgiY6oii6hnAc130_assertion wasDerivedFrom befree-2016 NP1099141.RAhPwWF9o6pyDluqa89zdze90PwhP6AfSgiY6oii6hnAc130_provenance.
- NP1099141.RAhPwWF9o6pyDluqa89zdze90PwhP6AfSgiY6oii6hnAc130_assertion wasGeneratedBy ECO_0000203 NP1099141.RAhPwWF9o6pyDluqa89zdze90PwhP6AfSgiY6oii6hnAc130_provenance.